Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lichtenegger

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Journal of Computer Assisted Tomography|May 1, 1997
Boeck sarcoidosis of the breast: mammographic, ultrasound, and MR findingsP P Kenzel, J Hadijuana, N Hosten, et al.
Zentralblatt Fur Gynakologie|May 5, 2000
[Dose intensified adjuvant chemotherapy in high risk breast carcinoma with 4-9 positive lymph nodes]D Elling, J Krocker, S Kümmel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 2007
Online tumor conference in the clinical management of gynecological cancer: experience from a pilot study in GermanyR Chekerov, C Denkert, D Boehmer, et al.
The Journal of Obstetrics and Gynaecology Research|January 9, 2001
Primary mucinous adenocarcinoma of the appendix: a rare entity in the differential diagnosis of ovarian cancerJ Sehouli, O J Kopetsch, J Ricke, et al.
Gynecologic Oncology|December 5, 2009
Sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: results of a multicenter phase II study of the northeastern German society of gynecological oncologyG Oskay-Ozcelik, R Chekerov, H Sommer, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2008
Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trialPeter Schmid, J Krocker, R Kreienberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapyJ Sehouli, D Stengel, G Oskay, et al.
Cytokine|February 19, 2013
Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: results of a companion protocol of the randomized, NOGGO-AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and paclitaxel containing sequential radiotherapyE I Braicu, C Fotopoulou, R Chekerov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer: results of a multicenter phase-II trialJ Sehouli, G Oskay-Ozcelik, J Kühne, et al.
Gynakologisch-Geburtshilfliche Rundschau|April 24, 2008
[Imatinib--a possible therapeutic option for cervical carcinoma: results of a preclinical phase I study]S Kummel, H Heidecke, B Brock, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Journal of Computer Assisted Tomography|May 1, 1997
Boeck sarcoidosis of the breast: mammographic, ultrasound, and MR findingsP P Kenzel, J Hadijuana, N Hosten, et al.
Zentralblatt Fur Gynakologie|May 5, 2000
[Dose intensified adjuvant chemotherapy in high risk breast carcinoma with 4-9 positive lymph nodes]D Elling, J Krocker, S Kümmel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 2007
Online tumor conference in the clinical management of gynecological cancer: experience from a pilot study in GermanyR Chekerov, C Denkert, D Boehmer, et al.
The Journal of Obstetrics and Gynaecology Research|January 9, 2001
Primary mucinous adenocarcinoma of the appendix: a rare entity in the differential diagnosis of ovarian cancerJ Sehouli, O J Kopetsch, J Ricke, et al.
Gynecologic Oncology|December 5, 2009
Sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: results of a multicenter phase II study of the northeastern German society of gynecological oncologyG Oskay-Ozcelik, R Chekerov, H Sommer, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2008
Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trialPeter Schmid, J Krocker, R Kreienberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapyJ Sehouli, D Stengel, G Oskay, et al.
Cytokine|February 19, 2013
Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: results of a companion protocol of the randomized, NOGGO-AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and paclitaxel containing sequential radiotherapyE I Braicu, C Fotopoulou, R Chekerov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer: results of a multicenter phase-II trialJ Sehouli, G Oskay-Ozcelik, J Kühne, et al.
Gynakologisch-Geburtshilfliche Rundschau|April 24, 2008
[Imatinib--a possible therapeutic option for cervical carcinoma: results of a preclinical phase I study]S Kummel, H Heidecke, B Brock, et al.
Pageof 12